ASBP
Aspire Biopharma
ASBP
ASBP
25 hedge funds and large institutions have $646K invested in Aspire Biopharma in 2025 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Holders
25
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$88.3K | |
| 2 | +$51.5K | |
| 3 | +$41.8K | |
| 4 |
CA
Crewe Advisors
Salt Lake City,
Utah
|
+$38.4K |
| 5 |
RA
Resolute Advisors
San Francisco,
California
|
+$17.1K |
Top Sellers
| 1 | -$36.2K | |
| 2 | -$25.4K | |
| 3 | -$5.15K | |
| 4 |
Goldman Sachs
New York
|
-$5.03K |
| 5 |
SRL
Scientech Research LLC
Jersey City,
New Jersey
|
-$4.44K |
